Spire Bushey Hospital introduces advanced new treatment for enlarged prostate or benign prostatic hyperplasia

Spire Bushey Hospital has introduced Aquablation therapy for the treatment of enlarged prostates or benign prostatic hyperplasia, with several patients already benefiting from this improved treatment for one of the most common health complications faced by men over the age of 50.

Aquablation therapy is an advanced, minimally invasive treatment for BPH that combines imaging and robotic technology to guide a heat-free waterjet for precise tissue removal. 

One of the most important benefits of Aquablation therapy over alternative BPH treatments is that it will improve the preservation of continence and sexual function for patients. Advanced software and robotics allow the surgeon to accurately target diseased tissue before using a heat-free water jet to remove only the targeted tissue.

The most common complications with alternative surgical solutions are continence, and issues with erections and ejaculation. Clinical studies have shown preserved incontinence and erection function in all men who have received Aquablation therapy, while 90% retained their ejaculatory function, delivering a considerable reduction and low incidence of irreversible complications. Patients can also expect long-lasting relief from BPH symptoms with significant improvements in symptoms recorded for up to five years following the procedure.

The recovery process for Aquablation therapy is also more comfortable, with patients able to leave the hospital without a catheter, often the same day.

To find out more or book an appointment with a consultant, please click here.